scholarly article | Q13442814 |
P50 | author | Gianluca Caridi | Q42709622 |
Pietro A Canetta | Q56855760 | ||
Yifu Li | Q56951916 | ||
Chad A Newton | Q88043113 | ||
Krzysztof Kiryluk | Q90776285 | ||
Anna Materna-Kiryluk | Q100383298 | ||
P2093 | author name string | Ali G Gharavi | |
Miguel Verbitsky | |||
Simone Sanna-Cherchi | |||
Gerald B Appel | |||
Jai Radhakrishnan | |||
Vaidehi Jobanputra | |||
Sneh Lata | |||
Francesca Lugani | |||
Vivette D'Agati | |||
Glen S Markowitz | |||
Corinne Antignac | |||
Christine K Garcia | |||
Andrew S Bomback | |||
Marcin Zaniew | |||
Wooin Ahn | |||
Luca Rampoldi | |||
Adele Mitrotti | |||
Aditya Mattoo | |||
David A Fasel | |||
Jordan Nestor | |||
Maddalena Marasa | |||
Maya K Rao | |||
Rik Westland | |||
Emily Groopman | |||
Hila Rasouly | |||
Lindsey M Slater | |||
P2860 | cites work | Exome sequencing identifies the cause of a mendelian disorder | Q24607742 |
dbSNP: the NCBI database of genetic variation | Q24608672 | ||
Analysis of protein-coding genetic variation in 60,706 humans | Q26831376 | ||
A method and server for predicting damaging missense mutations | Q27860835 | ||
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization | Q28283679 | ||
ClinVar: public archive of interpretations of clinically relevant variants | Q28603051 | ||
A framework for the interpretation of de novo mutation in human disease | Q29031873 | ||
Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component | Q29147385 | ||
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data | Q29547161 | ||
Prevalence of chronic kidney disease in the United States | Q29614191 | ||
Exome sequencing as a tool for Mendelian disease gene discovery | Q29615382 | ||
A general framework for estimating the relative pathogenicity of human genetic variants | Q29615730 | ||
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction | Q30301147 | ||
Genic intolerance to functional variation and the interpretation of personal genomes | Q31129974 | ||
Mutations in 12 known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract | Q33692509 | ||
Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive | Q33692595 | ||
Rapid detection of monogenic causes of childhood-onset steroid-resistant nephrotic syndrome | Q33715807 | ||
Sequencing studies in human genetics: design and interpretation. | Q33981063 | ||
Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing | Q34181261 | ||
FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair | Q34286677 | ||
Familial clustering of ESRD in the Norwegian population | Q34292853 | ||
Molecular genetic testing and the future of clinical genomics | Q34345162 | ||
Clinical whole-exome sequencing for the diagnosis of mendelian disorders | Q34413680 | ||
Genome sequencing identifies major causes of severe intellectual disability | Q34422838 | ||
A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome | Q34445136 | ||
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology | Q34465792 | ||
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics | Q34544874 | ||
Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis | Q34577537 | ||
Clinical exome sequencing for genetic identification of rare Mendelian disorders | Q34782655 | ||
Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening | Q35554660 | ||
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways | Q35624305 | ||
Exome sequencing can improve diagnosis and alter patient management | Q35641969 | ||
Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita | Q35719990 | ||
Genomic imbalances in pediatric patients with chronic kidney disease | Q35720119 | ||
The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies | Q36324942 | ||
The intolerance to functional genetic variation of protein domains predicts the localization of pathogenic mutations within genes | Q36476263 | ||
Exome sequencing and the genetic basis of complex traits | Q37056084 | ||
Exome Sequencing and the Management of Neurometabolic Disorders. | Q37171865 | ||
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer | Q37179254 | ||
Whole-exome sequencing in the molecular diagnosis of individuals with congenital anomalies of the kidney and urinary tract and identification of a new causative gene. | Q37716314 | ||
Recommendations for the integration of genomics into clinical practice | Q38376302 | ||
An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis | Q39014952 | ||
Familial clustering of end-stage renal disease in blacks with lupus nephritis | Q43532820 | ||
Bone marrow failure and developmental delay caused by mutations in poly(A)-specific ribonuclease (PARN). | Q47073215 | ||
The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial | Q47717402 | ||
Rare Genetic Variants in PARN Are Associated with Pulmonary Fibrosis in Families | Q47914471 | ||
Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. | Q47997703 | ||
Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing. | Q48133265 | ||
Carriers of Autosomal Recessive Alport Syndrome with Thin Basement Membrane Nephropathy Presenting as Focal Segmental Glomerulosclerosis in Later Life. | Q53413309 | ||
Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine | Q57250562 | ||
Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy | Q78078326 | ||
Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis | Q86084087 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chronic renal insufficiency | Q736715 |
P304 | page(s) | 100-109 | |
P577 | publication date | 2017-12-05 | |
P1433 | published in | Annals of Internal Medicine | Q564416 |
P1476 | title | Whole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot Study. | |
P478 | volume | 168 |
Q94103592 | 15th International Symposium on IgANephropathy - IIgANN 2018, Buenos Aires, September 27-29, 2018: Summaries |
Q89636205 | At the Research-Clinical Interface: Returning Individual Genetic Results to Research Participants |
Q57990749 | Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition |
Q90252735 | COL4A3 Gene Variants and Diabetic Kidney Disease in MODY |
Q90566753 | Cases in Precision Medicine: APOL1 and Genetic Testing in the Evaluation of Chronic Kidney Disease and Potential Transplant |
Q99557464 | Clinical impact of genomic testing in patients with suspected monogenic kidney disease |
Q89994963 | Clinical utility of genomic analysis in adults with idiopathic liver disease |
Q92430472 | Comprehensive evaluation of a prospective Australian patient cohort with suspected genetic kidney disease undergoing clinical genomic testing: a study protocol |
Q98292982 | DNAJB11-Related Atypical ADPKD in a Kidney Transplant Donor |
Q89367578 | Deep Phenotyping on Electronic Health Records Facilitates Genetic Diagnosis by Clinical Exomes |
Q92539562 | Diagnostic Yield of Next-Generation Sequencing in Patients With Chronic Kidney Disease of Unknown Etiology |
Q92924458 | Exome Sequencing in Clinical Hepatology |
Q58792928 | Exome sequencing of an adolescent with nonalcoholic fatty liver disease identifies a clinically actionable case of Wilson disease |
Q64969525 | Genetic Susceptibility to Chronic Kidney Disease - Some More Pieces for the Heritability Puzzle. |
Q91708296 | Genome-Wide Study Updates in the International Genetics and Translational Research in Transplantation Network (iGeneTRAiN) |
Q57048905 | Genome-wide polygenic risk predictors for kidney disease |
Q47200436 | Genomic medicine for kidney disease |
Q64080824 | Infectious Disease Risk in Dialysis Patients: A Transdisciplinary Approach |
Q92786626 | Isolated proteinuria due to CUBN homozygous mutation - challenging the investigative paradigm |
Q63684344 | Meso-American nephropathy: what we have learned about the potential genetic influence on chronic kidney disease development |
Q91655484 | Monogenic causes of chronic kidney disease in adults |
Q57175118 | Opportunities and Challenges for Genetic Studies of End-Stage Renal Disease in Canada |
Q90251531 | Pediatric Liddle Syndrome Caused by a Novel SCNN1G Variant in a Chinese Family and Characterized by Early-onset Hypertension |
Q91950321 | Personalized medicine in chronic kidney disease by detection of monogenic mutations |
Q93203299 | Pitfalls and Challenges of Consenting to Genetic Research Studies |
Q98513883 | Rare genetic causes of complex kidney and urological diseases |
Q57153302 | Renal Genetics in Australia: Kidney Medicine in the Genomic Age |
Q92485087 | Role of Deleterious Rare Alleles for Acute-Onset Diffuse Interstitial Lung Disease in Collagen Diseases |
Q90266382 | The Challenges of Chromosome Y Analysis and the Implications for Chronic Kidney Disease |
Q90712113 | The copy number variation landscape of congenital anomalies of the kidney and urinary tract |
Q96230896 | Unravelling the complex genetics of common kidney diseases: from variants to mechanisms |
Q64977645 | Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma. |
Search more.